[Body composition: decision making support in oncology, current and future practices].
This review aims to highlight the synergies between clinical nutrition, body composition and cancer treatment. Body composition is already a powerful tool to diagnose cachexia and determine response to nutritionnal intervention. It may be used in the future to fine tune body surface area (BSA) based drug dose determination thanks to its capacity to predict chemotoxicity. The overall aim of nutritionnal intervention is to optimize the oncological care by reducing treatment interruptions and improving the quality of life. However, to achieve this goal, nutritionnal intervention has to be very accurate as most of the failures result from inappropriate intervention.
Institut multidisciplinaire d'oncologie, Clinique de Genolier, 1272 Genolier. njacquelin@genolier.net
Nathalie
N
Jacquelin-Ravel
Matti
M
Aapro
Claude
C
Pichard
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001823:Body Composition / Q000187:drug effects / Q000502:physiology*; D002100:Cachexia / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy / Q000379:methods / Q000639:trends; D003657:Decision Making; D003661:Decision Support Techniques; D004035:Diet Therapy / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D008495:Medical Oncology / Q000379:methods* / Q000639:trends*; D008954:Models, Biological; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D044623:Nutrition Therapy / Q000379:methods / Q000706:statistics & numerical data; D009765:Obesity / Q000150:complications / Q000628:therapy